Early Cancer Detection
ADPS precisely diagnose ctDAN of the 1st and 2nd stage of cancer patients.
Soon or later, GENECAST will complete early diagnosis platform of cancer.
ADPS’s high detection sensitivity enables to manage prognosis of cancer.
Also, possible to manage recurrence of cancer by detecting remain cancer.
Precision Medicine(Companion Diagnostics)
ADPS ensures high detection sensitivity that promises companion diagnosis with liquid biopsy.
Moreover, could dramatically reduce the cost of developing new drugs for targeted therapy.